Trial Profile
A randomized, double blind, parallel group, multi center, active and placebo controlled trial to evaluate the analgesic efficacy and safety of multiple doses of CG5503 IR [immediate release] [tapentadol] for postoperative pain following bunionectomy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Nov 2011
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary) ; Morphine
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Grunenthal
- 17 Dec 2009 Actual patient number (291) added as reported by ClinicalTrials.gov.
- 10 Mar 2008 New trial record.